Assessment of the efficacy of successive endocrine therapies in hormone receptor-positive and HER2-negative metastatic breast cancer: a real-life multicentre national study.

•Contrary to guidelines, endocrine therapy was prescribed to a minority of patients.•In our real-life cohort, median PFS compared favourably with clinical trial results.•Patients with a low tumour burden may achieve prolonged response.